Literature DB >> 3493674

Detection of coronary artery disease with 13N-ammonia and high-resolution positron-emission computed tomography.

Y Yonekura, N Tamaki, M Senda, R Nohara, H Kambara, Y Konishi, H Koide, S A Kureshi, H Saji, T Ban.   

Abstract

In order to evaluate the detectability of coronary artery disease (CAD) with positron-emission computed tomography (PET), we performed 13N-ammonia myocardial PET scanning at rest and with exercise loading in 20 normal subjects and 40 patients with CAD, by means of a high-resolution, multi-slice, whole-body PET scanner. Myocardial PET scanning was performed 3 minutes after injection of 13N-ammonia at rest and during exercise. The circumferential profile analysis of resting PET images revealed regional hypoperfusion in 96% of CAD patients with previous myocardial infarction and in 29% of those without infarction. Exercise PET studies showed high sensitivity (93%) in detecting CAD without myocardial infarction, whereas no abnormal hypoperfusion was detected in normal subjects. Segmental analysis of regional myocardial perfusion with exercise stress identified 67 of 75 stenosed vessels (89%). We conclude that 13N-ammonia myocardial PET with exercise loading provides high-quality tomographic images of regional myocardial perfusion and is a valuable technique for detecting CAD.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493674     DOI: 10.1016/0002-8703(87)90702-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

Review 1.  Myocardial perfusion imaging agents: SPECT and PET.

Authors:  George A Beller; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

2.  Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Pro.

Authors:  Rob S B Beanlands; George Youssef
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 3.  Myocardial hibernation and stunning: from physiological principles to clinical practice.

Authors:  S R Redwood; R Ferrari; M S Marber
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

Review 4.  Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.

Authors:  A S Iskandrian; M S Verani; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

Review 5.  Absolute quantitation of myocardial blood flow: the technical and clinical prospects for single-photon emission computed tomography.

Authors:  J Maddahi; J Czernin
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

6.  A new subtraction method for obtaining myocardial perfusion images with oxygen-15 water and positron emission tomography.

Authors:  M Senda; S Nishizawa; Y Yonekura; N Tamaki; H Saji; T Mukai; J Konishi
Journal:  Ann Nucl Med       Date:  1988-11       Impact factor: 2.668

Review 7.  [Examination of myocardial perfusion with positron emission tomography: a clinically useful and valid method?].

Authors:  J vom Dahl
Journal:  Herz       Date:  1997-02       Impact factor: 1.443

Review 8.  Clinical review of attenuation-corrected cardiac SPECT.

Authors:  J R Corbett; E P Ficaro
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

Review 9.  Recent advances in cardiac positron emission tomography in the clinical management of the cardiac patient.

Authors:  Robert J Gropler; Pablo Soto
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

Review 10.  Attenuation correction for single photon emission computed tomography myocardial perfusion imaging.

Authors:  James R Corbett; James N Kritzman; Edward P Ficaro
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.